Metastatic Prostate Cancer

The podcast discusses the treatment options for castrate sensitive and resistant prostate cancer, including oral anti-androgen medications, docetaxel chemotherapy, radium-223, and cabazitaxel. It also explores the importance of understanding drugs and genetic testing, and discusses second-line treatments such as chemo with Kepazzi-Taxel and immunotherapy with Pembrolycumab. Additionally, it covers monitoring strategies using PSA levels and imaging, treatment options for small cell prostate cancer, castrate resistance, and genetic testing for stage four patients.